Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Pharmacogenomics J. 2013 Mar 26;14(1):63–69. doi: 10.1038/tpj.2013.6

Figure 3.

Figure 3

Synapsin IIa mRNA in post-mortem dorsolateral prefrontal cortex brain specimens. Real Time RT-PCR was performed on 105 specimens obtained from the SFNC. Synapsin IIa was significantly reduced in patients with schizophrenia (SCZ) (P<0.0001) compared to normal controls (CTL) and patients with bipolar disorder (BPD). Data are presented as box plots of log-transformed mean synapsin IIa mRNA expressions with shaded circles identifying outliers.